Teva anticipates EBITDA recovery post-2025 as Austedo and Uzedy grow and generic Revlimid faces rising competition.

A total of 5 analyst ratings have been received for Teva Pharmaceutical Indus, with the consensus rating being Buy. The ...

For reference, Seeking Alpha's Quant system is driven by powerful computer processing and SA's special 'Quantamental' ...

My role at Viatris has enabled me to grow professionally and contribute at a broader industry level. This year, I was given the opportunity to join the Medical Device Task Force of Medicines for ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD (metabolic dysfunction-associated steatotic liver disease – previously called ...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...